Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-24Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma [Phase 2, Phase 3]
This clinical trial update covers Phase 2 and Phase 3 evaluation of bone marrow transplantation for patients with leukemia, myelodysplastic …
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma [Phase 1]
A Phase 1 trial evaluating Bryostatin-1 in combination with high-dose cytarabine in patients with refractory or relapsed leukemia or lymphom…
-
CLINICAL_TRIALS research · 2010-01-28Clinical Trial Update: Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders [Phase 2]
A Phase 2 clinical trial update evaluating stem cell transplantation for hematological cancers or related disorders, listing conditions such…
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [Phase 1]
This Phase 1 trial evaluating 12-O-tetradecanoylphorbol-13-acetate in hematologic cancers and bone marrow disorders was terminated.
-
CLINICAL_TRIALS trial_result · 2009-11-16Clinical Trial Update: Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
This update reports on a completed trial comparing piperacillin-tazobactam alone versus with a glycopeptide in neutropenic patients with hem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Amifostine for Head and Neck Irradiation in Lymphoma [Phase 2]
Phase 2 trial update evaluating amifostine to protect normal tissues during head and neck irradiation in patients with lymphoma. The study i…
-
CLINICAL_TRIALS trial_result · 2009-10-09Clinical Trial Update: A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) [Phase 1]
A Phase I study evaluating the safety and tolerability of intravenous EZN-2208 in patients with advanced solid tumors or lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma [Phase 2]
Phase 2 trial results evaluate rasburicase as a uricolytic therapy to treat hyperuricemia in patients with leukemia or lymphoma.
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 [Phase 1]
A Phase I open-label, dose-escalation study of AZD4877 in lymphoma and Non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors [Phase 4]
Phase 4 study comparing aprepitant plus palonosetron versus granisetron for the prevention of chemotherapy-induced nausea and vomiting in pa…
-
CLINICAL_TRIALS trial_result · 2009-09-03Clinical Trial Update: Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor umbilical cord blood transplant by intra-bone-marrow injection for hematologic cancers; trial term…
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 dose-escalation study of CX-3543 in patients with advanced solid tumors or lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
A Phase 1 dose-escalation study of Quarfloxin in patients with advanced solid tumors or lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors [Phase 1]
A Phase 1 study of oral CNF2024 (BIIB021) in advanced solid tumors and lymphoma has completed.
-
CLINICAL_TRIALS research · 2009-06-09Clinical Trial Update: Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer [Phase 1]
This Phase 1 clinical trial update covers a radiolabeled monoclonal antibody combined with chemotherapy and peripheral stem cell transplanta…
-
CLINICAL_TRIALS trial_result · 2009-05-11Clinical Trial Update: Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies [Phase 2]
Phase 2 clinical trial update examining chemotherapy-related anemia in patients with non-myeloid malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2009-03-30Clinical Trial Update: Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy [Phase 4]
Phase 4 study evaluating rasburicase for treatment or prevention of hyperuricemia associated with tumor lysis syndrome in patients with rela…
-
CLINICAL_TRIALS trial_result · 2009-03-17Clinical Trial Update: Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab [NA]
A clinical trial update assessing the antibody response to the Hepatitis B vaccine in older lymphoma patients undergoing rituximab therapy.
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas [NA]
Completed clinical trial evaluating CD133+ selected autologous hematopoietic stem cell chemotherapy in children with solid tumors and lympho…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Phase 3]
This is a Phase 3 trial evaluating combination chemotherapy with or without idarubicin followed by peripheral stem cell transplantation in p…
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) [Phase 2]
Phase 2 feasibility and efficacy study of a conditioning regimen using fludarabine, busulfan, and total body irradiation before allogeneic h…
-
CLINICAL_TRIALS trial_result · 2008-12-04Clinical Trial Update: STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors [Phase 1]
Phase 1 clinical trial update for STA-5312 administered on alternate weekdays every two weeks in patients with hematologic malignancies and …
-
CLINICAL_TRIALS trial_result · 2008-10-13Clinical Trial Update: Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas [Phase 1]
A Phase 1 dose-escalation study of SB-485232 given intravenously every 28 days in adults with solid tumors or lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-22Clinical Trial Update: Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy [Phase 1]
A Phase 1 pilot study evaluated a four-drug combination of temozolomide, vincristine (Oncovin), irinotecan (Camptosar), and an oral antibiot…
-
CLINICAL_TRIALS research · 2008-08-26Clinical Trial Update: Healthy Exercise for Lymphoma Patients (HELP) [Phase 3]
Phase 3 trial update for an exercise-based intervention in lymphoma patients; current status is unknown.